The Current Ratio as of September 2024 (TTM) for Calithera Biosciences, Inc. (CALA) is 3.60

According to Calithera Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.60. This represents a change of -11.76% compared to the average of 4.08 of the last 4 quarters.

Calithera Biosciences, Inc. (CALA) Historical Current Ratio (quarterly & annually)

How has CALA Current Ratio performed in the past?

The mean historical Current Ratio of Calithera Biosciences, Inc. over the last ten years is 11.79. The current 3.60 Current Ratio has changed 2.96% with respect to the historical average. Over the past ten years (40 quarters), CALA's Current Ratio was at its highest in in the March 2015 quarter at 25.65. The Current Ratio was at its lowest in in the September 2013 quarter at 0.

Calithera Biosciences, Inc. (CALA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Calithera Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Calithera Biosciences, Inc. (CALA) Average Current Ratio

How has CALA Current Ratio performed in the past?

The current Current Ratio of Calithera Biosciences, Inc. (CALA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Calithera Biosciences, Inc. (CALA) Current Ratio vs. Peers

How is CALA’s Current Ratio compared to its peers?

Calithera Biosciences, Inc.’s Current Ratio is less than Abeona Therapeutics Inc. (0), less than Affimed N.V. (7.48), greater than Checkpoint Therapeutics, Inc. (2.71), greater than Adaptimmune Therapeutics plc (0.26), greater than Mereo BioPharma Group plc (3.09), less than Pieris Pharmaceuticals, Inc. (6.07), less than PDS Biotechnology Corporation (3.95), less than Leap Therapeutics, Inc. (3.84), less than Kodiak Sciences Inc. (5.10), less than Galmed Pharmaceuticals Ltd. (10.59), less than Adverum Biotechnologies, Inc. (6.48), less than Ardelyx, Inc. (7.99), less than Zura Bio Limited (4.21), less than Hepion Pharmaceuticals, Inc. (12.57), less than AVROBIO, Inc. (5.62), less than Verastem, Inc. (26.17), greater than null (3.28),

Build a custom stock screener for Calithera Biosciences, Inc. (CALA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Calithera Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Calithera Biosciences, Inc. (CALA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Calithera Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.